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Higher Risk of Stent Thrombosis in Poor Responders to Clopidogrel
Buonamici and colleagues measured platelet reactivity after clopidogrel loading inover 800 patients undergoing percutaneous coronary intervention with a drug-
eluting stent (DES) and then followed them for evidence of stent thrombosis over the
next 6months.Overall, 3.1%of patients experienced late stent thrombosis and13%of
patients were considered nonresponders to clopidogrel. The incidence of stent throm-
bosis was 8.6% in nonresponders versus 2.3% in responders. In a multivariable
analysis, the hazard ratio for nonresponders was 3.1. Reduced responsiveness to
clopidogrel appears to be an important risk factor for late stent thrombosis with DES.
See pages 2312 and 2318.
Heart Failure
Aerobic Exercise Improves LV Remodeling
Exercise training is now recommended by a number of international scientificorganizations for patients with mild to moderate heart failure (HF) symptoms,
but whether it can improve left ventricular (LV) function remains controversial.
Haykowsky and colleagues performed ameta-analysis of studies inwhich patients with
HF and systolic dysfunction were randomized to exercise training or standard therapy
and echocardiographic parameters were reported pre- and post. Fourteen trials re-
ported ejection fraction (EF) data (812 patients). Aerobic training significantly im-
proved EF by 2.6%. End-diastolic and -systolic volume also improved with aerobic
training. No benefits were seen with either combined aerobic and strength training or
strength training alone.This study confirms that aerobic exercise canmodestly improve
LV remodeling. See pages 2329 and 2337.
Heart Failure
Decreased Efficacy of Bone Marrow Cells from Patients With Ischemic
Cardiomyopathy
Kissel and colleagues compared the total number of endothelial progenitors cells(EPCs), their migration to vascular endothelial growth factor, and their colony-
forming capacity in normal controls and patients with ischemic or idiopathic chronic
congestive heart failure (CHF). The number of EPCs was reduced in CHF, regardless
of its etiology. In contrast, the migratory capacity and colony forming ability were
impaired only in subjects with ischemic cardiomyopathy. Ischemic cardiomyopathy is
associated with a selective impairment of progenitor cell function in the bone marrow
and in the peripheral blood, which may contribute to an unfavorable left ventricular
remodeling process. See page 2341.
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Heart Rhythm Disorders
Amiodarone-Induced Thyrotoxicosis
Amiodarone-induced thyrotoxicosis (AIT) is a poorly understood complication ofamiodarone therapy. Conen and colleagues performed a retrospective review of
84 patients with AIT. Fifty-six percent of patients subsequently died or were hospital-
ized for a cardiac-related diagnosis, either related to the underlying cardiac problem or
as a direct result of the AIT. Twenty-seven patients received prednisone; there was no
difference in time to normalization of free T4 between patients receiving and those not
receivingprednisone, althoughpatientswho receivedprednisoneweremore likely tobe
subsequently hospitalized. Patients with AIT are likely to be hospitalized for cardiac
reasons; prednisone appears to be ineffective and may worsen long-term outcomes,
though a randomized trial is needed in order to determine optimal strategies. See
page 2350. See figure.
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Biomarkers
MPO May Help Clarify Risk in Patients With Chronic HF
Myeloperoxidase (MPO) is released during inflammation; its measurement canbe used as a marker of leukocyte activation and oxidant stress and has been
shown to help stratify risk in subjects presenting with chest pain. Tang and colleagues
measured MPO levels in 140 subjects with stable systolic dysfunction who also
underwent echocardiography and measurement of B-type natriuretic peptide (BNP)
levels. Elevated plasma MPO levels were associated with increased likelihood of
restrictive diastolic filling and were predictive of long-term clinical outcomes. MPO
levels remained predictive after adjustment for age, left ventricular ejection fraction,
plasma BNP, creatinine clearance, or diastolic stage. Measuring MPO appears to
provide additional prognostic information in patients with systolic heart failure (HF).
See page 2364. See figure.
